Physician profile
Mohammad Arshad
NPI 1386730158
$830.53
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $299 · 2020: $133 · 2021: $18.63 · 2023: $39.36 · 2024: $341.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $341 · Food and Beverage: $39.36.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $340.61 |
| Food and Beverage | $39.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spineology INC. | $340.61 | 2024 | Optimesh Expandable Interbody Fusion System |
| Pfizer INC. | $171.33 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $98.84 | 2019-2023 | Farxiga |
| Novo Nordisk INC | $96.15 | 2019-2023 | Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.94 | 2019-2020 | |
| Allergan, INC. | $23.47 | 2020 | |
| Amgen INC. | $18.58 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.99 | 2019 | |
| Glaxosmithkline, LLC. | $11.71 | 2020 | |
| Biodelivery Sciences International, INC. | $10.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Arshad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.